One such promising biomarker is the Advanced lung cancer inflammation index (ALI), a nutritional inflammation biomarker based on body mass index (BMI), serum albumin, neutrophil, and lymphocyte counts, which was first proposed by Jafri et al. (16). The gene discussed is ALB; the disease is lung carcinoma.